Rheumatology Doctors in Olympia Fields, IL Accepting Medicare

3 Rheumatology doctors found. Showing 1 - 3

Charles E Geringer, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 3700 W 203rd St Ste 209, Olympia Fields, IL 60461 Phone: 708-679-2884    Fax: 708-679-2836

Dr. Raymond Eugene Kazmar, M.D. Internal Medicine - Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 2555 W. Lincoln Hwy, Suite 200, Olympia Fields, IL 60461 Phone: 708-481-4900    Fax: 708-481-9440

Dr. Veena Nayak, M.D. Internal Medicine - Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 20060 Governors Dr, Olympia Fields, IL 60461 Phone: 708-283-2600    Fax: 708-833-7248

News Archive

Type 2 diabetes drug may be used to treat heart failure with preserved ejection fraction

Researchers at the University of Arizona have discovered that metformin, a drug commonly used to treat type 2 diabetes, might also be used to treat heart failure with preserved ejection fraction, a condition that is predicted to affect over 8% of people ages 65 or older by the year 2020.

Locally procured drugs can be as effective as IQA drugs for treating MDR-TB in Pakistan

Locally-sourced antibiotics can be as effective as 'internationally quality-assured' (IQA) antibiotics for treating multidrug-resistant tuberculosis (MDR-TB) in Pakistan, and may help avoid delays in starting treatment while programmes wait for drugs to arrive from overseas, according to new research published in PLOS ONE.

Studies demonstrate new approaches to treating and preventing Parkinson's disease

A trio of studies from the Perelman School of Medicine at the University of Pennsylvania demonstrate new approaches to understanding, treating and potentially staving off Parkinson's disease (PD). Studies show that factors such as estrogen exposure and statin use have an impact on the onset of Parkinson's disease.

Teva's DuoResp Spiromax receives EC marketing authorization for treatment of asthma, COPD

Teva Pharmaceutical Industries Ltd., announced today that the European Commission has granted marketing authorization for DuoResp Spiromax for the treatment of patients with asthma and chronic obstructive pulmonary disease (COPD) where the use of a combination of an inhaled corticosteroid and long-acting beta2-adrenoceptor agonist is appropriate.

Researchers discover new molecule that allows for multiplication of stem cells in cord blood

Investigators from the Institute for Research in Immunology and Cancer at the Université de Montréal have just published, in the prestigious magazine Science, the announcement of the discovery of a new molecule, the first of its kind, which allows for the multiplication of stem cells in a unit of cord blood.

Read more Medical News

› Verified 4 days ago